Overview
The goal of this clinical trial is to compare protein supplements in patients with kidney failure on dialysis. The main questions it aims to answer are:
- To determine whether the supplementation of egg white protein pudding in a population of individuals with kidney failure on dialysis is feasible.
- To determine whether egg white protein pudding supplementation improves serum albumin similar to other standard nutritional supplements.
- To determine the effects of the egg white protein pudding on frailty measures, dietary intakes and analytes in the blood and urine. Participants will receive either the egg white pudding (experimental) or control (Ensure plus) at the end of their dialysis treatments 3-days per week for 12 weeks.
Eligibility
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the trial
- Male or female aged ≥18 years with CKD
- On chronic in-center hemodialysis for > 3 months
- Serum albumin <35 g/L
- No expected change in dialysis modality or relocation outside of Winnipeg during the intervention period (12 weeks)
Exclusion Criteria:
- Allergy to eggs
- History of renal transplant
- Serum albumin ≥ 35 g/L
- Bowel diseases
- Cancer
- Pregnancy
- Receiving chemotherapy treatment
- Inability to consume treatment product
- Allergy to study treatment ingredients
- Planning on starting an exercise program during the duration of the trial
- Inability to obtain written informed consent